Continuing Education
New Options for Patients: Latest Oncology Drug Trends On-Demand (NCODA Fall Summit 2024)
Best Suited For: Pharmacist, Pharmacy Technician, Nurse
CE Credits: 1 hours
Related Topics: New Drug Approvals, Medicare Policy, Medically Integrated Pharmacy, Operational Challenges in Oncology Pharmacy, Clinical Trial Design
Activity Description
This CE session aims to educate learners on the latest trends in oncology drugs, focusing on top oncology products and cancer incidences over the past five years. The discussion will delve into the analysis of research and development of solid tumor diagnosis, as well as the expansion of boundaries in cancer drug development within the industry. Additionally, the presentation will explore the increased access for cancer patients and the rising expenditure in new oncology markets.
CE Credit: 1 hour
Fee: This activity does not require payment to register.
- Identify the United States (US) trends in the oncology market.
- Discuss emerging research and development for various cancer trials and disease states.
- Recognize the use of scientific advances in oncology to increase patient access to care.
- Compare and contrast Global vs US spending on Oncology treatment regimens.
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted will be viewable in your CPE Monitor profile within 24 hours.
